Titre : Double couche lipidique

Double couche lipidique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Transferrin
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Double couche lipidique : Questions médicales les plus fréquentes", "headline": "Double couche lipidique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Double couche lipidique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-21", "dateModified": "2025-02-15", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Double couche lipidique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Membrane artificielle", "url": "https://questionsmedicales.fr/mesh/D008567", "about": { "@type": "MedicalCondition", "name": "Membrane artificielle", "code": { "@type": "MedicalCode", "code": "D008567", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "J01.637.087.500" } } }, "about": { "@type": "MedicalCondition", "name": "Double couche lipidique", "alternateName": "Lipid Bilayers", "code": { "@type": "MedicalCode", "code": "D008051", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "John F Nagle", "url": "https://questionsmedicales.fr/author/John%20F%20Nagle", "affiliation": { "@type": "Organization", "name": "Department of Physics , Carnegie Mellon University , Pittsburgh , Pennsylvania 15213 , United States." } }, { "@type": "Person", "name": "Jinyoung Seo", "url": "https://questionsmedicales.fr/author/Jinyoung%20Seo", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, South Korea." } }, { "@type": "Person", "name": "Sungi Kim", "url": "https://questionsmedicales.fr/author/Sungi%20Kim", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, South Korea." } }, { "@type": "Person", "name": "Ha H Park", "url": "https://questionsmedicales.fr/author/Ha%20H%20Park", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, South Korea." } }, { "@type": "Person", "name": "Jwa-Min Nam", "url": "https://questionsmedicales.fr/author/Jwa-Min%20Nam", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, South Korea." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Cisplatin Binding to Human Serum Transferrin: A Crystallographic Study.", "datePublished": "2023-01-05", "url": "https://questionsmedicales.fr/article/36602395", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.inorgchem.2c04206" } }, { "@type": "ScholarlyArticle", "name": "Quercetin prevents the ferroptosis of OPCs by inhibiting the Id2/transferrin pathway.", "datePublished": "2023-05-23", "url": "https://questionsmedicales.fr/article/37230155", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cbi.2023.110556" } }, { "@type": "ScholarlyArticle", "name": "Transferrin receptor 1 targeted nanomedicine for brain tumor therapy.", "datePublished": "2023-05-16", "url": "https://questionsmedicales.fr/article/36847174", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1039/d2bm02152h" } }, { "@type": "ScholarlyArticle", "name": "The interaction mechanism of plasma iron transport protein transferrin with nanoparticles.", "datePublished": "2023-04-13", "url": "https://questionsmedicales.fr/article/37060978", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ijbiomac.2023.124441" } }, { "@type": "ScholarlyArticle", "name": "COVID-19 compromises iron homeostasis: Transferrin as a target of investigation.", "datePublished": "2022-11-25", "url": "https://questionsmedicales.fr/article/36509021", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jtemb.2022.127109" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Technologie, industrie et agriculture", "item": "https://questionsmedicales.fr/mesh/D013676" }, { "@type": "ListItem", "position": 3, "name": "Produits manufacturés", "item": "https://questionsmedicales.fr/mesh/D008420" }, { "@type": "ListItem", "position": 4, "name": "Matériaux biomimétiques", "item": "https://questionsmedicales.fr/mesh/D040761" }, { "@type": "ListItem", "position": 5, "name": "Membrane artificielle", "item": "https://questionsmedicales.fr/mesh/D008567" }, { "@type": "ListItem", "position": 6, "name": "Double couche lipidique", "item": "https://questionsmedicales.fr/mesh/D008051" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Double couche lipidique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Double couche lipidique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Double couche lipidique", "description": "Comment identifier une double couche lipidique ?\nQuels tests peuvent évaluer la fluidité des membranes ?\nQuels indicateurs montrent une défaillance de la membrane ?\nComment les lipides sont-ils analysés dans les membranes ?\nQuels marqueurs biochimiques signalent des anomalies ?", "url": "https://questionsmedicales.fr/mesh/D008051?mesh_terms=Transferrin&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Double couche lipidique", "description": "Quels symptômes indiquent une dysfonction membranaire ?\nComment la fluidité affecte-t-elle la fonction cellulaire ?\nQuels effets sur la santé sont liés aux membranes ?\nQuels signes cliniques sont associés aux membranes ?\nComment les membranes influencent-elles l'immunité ?", "url": "https://questionsmedicales.fr/mesh/D008051?mesh_terms=Transferrin&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Double couche lipidique", "description": "Comment prévenir les maladies liées aux membranes ?\nQuels modes de vie favorisent la santé membranaire ?\nComment éviter l'oxydation des membranes ?\nQuels facteurs environnementaux affectent les membranes ?\nComment le stress influence-t-il la santé membranaire ?", "url": "https://questionsmedicales.fr/mesh/D008051?mesh_terms=Transferrin&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Double couche lipidique", "description": "Quels traitements ciblent les membranes cellulaires ?\nComment les lipides peuvent-ils être manipulés ?\nQuels suppléments peuvent améliorer la santé membranaire ?\nComment les antioxydants aident-ils les membranes ?\nQuels traitements sont utilisés pour les maladies membranaires ?", "url": "https://questionsmedicales.fr/mesh/D008051?mesh_terms=Transferrin&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Double couche lipidique", "description": "Quelles complications peuvent survenir avec des membranes altérées ?\nComment les membranes affectent-elles le cancer ?\nQuels troubles neurologiques sont liés aux membranes ?\nComment les infections impactent-elles les membranes ?\nQuelles sont les conséquences d'une défaillance membranaire ?", "url": "https://questionsmedicales.fr/mesh/D008051?mesh_terms=Transferrin&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Double couche lipidique", "description": "Quels facteurs génétiques influencent la santé membranaire ?\nComment l'alimentation impacte-t-elle les membranes ?\nQuels comportements augmentent le risque de maladies membranaires ?\nComment l'âge affecte-t-il la santé des membranes ?\nQuels facteurs environnementaux sont des risques pour les membranes ?", "url": "https://questionsmedicales.fr/mesh/D008051?mesh_terms=Transferrin&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier une double couche lipidique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'observation au microscope électronique révèle la structure en double couche." } }, { "@type": "Question", "name": "Quels tests peuvent évaluer la fluidité des membranes ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de diffusion de marqueurs fluorescents peuvent être utilisés." } }, { "@type": "Question", "name": "Quels indicateurs montrent une défaillance de la membrane ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Une augmentation de la perméabilité et des fuites de protéines sont des indicateurs." } }, { "@type": "Question", "name": "Comment les lipides sont-ils analysés dans les membranes ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'analyse par chromatographie permet d'étudier la composition lipidique." } }, { "@type": "Question", "name": "Quels marqueurs biochimiques signalent des anomalies ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des niveaux élevés de lipides oxydés peuvent indiquer des anomalies membranaires." } }, { "@type": "Question", "name": "Quels symptômes indiquent une dysfonction membranaire ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles métaboliques et des inflammations peuvent survenir." } }, { "@type": "Question", "name": "Comment la fluidité affecte-t-elle la fonction cellulaire ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Une fluidité altérée peut perturber le transport des protéines et des ions." } }, { "@type": "Question", "name": "Quels effets sur la santé sont liés aux membranes ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des maladies comme l'athérosclérose sont liées à des anomalies des membranes." } }, { "@type": "Question", "name": "Quels signes cliniques sont associés aux membranes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme l'œdème et la déshydratation peuvent être observés." } }, { "@type": "Question", "name": "Comment les membranes influencent-elles l'immunité ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les membranes régulent l'activation des cellules immunitaires et la signalisation." } }, { "@type": "Question", "name": "Comment prévenir les maladies liées aux membranes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée riche en acides gras essentiels aide à maintenir la santé." } }, { "@type": "Question", "name": "Quels modes de vie favorisent la santé membranaire ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "L'exercice régulier et l'hydratation adéquate sont essentiels." } }, { "@type": "Question", "name": "Comment éviter l'oxydation des membranes ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Consommer des aliments riches en antioxydants aide à protéger les membranes." } }, { "@type": "Question", "name": "Quels facteurs environnementaux affectent les membranes ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "La pollution et les toxines peuvent endommager les membranes cellulaires." } }, { "@type": "Question", "name": "Comment le stress influence-t-il la santé membranaire ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Le stress chronique peut altérer la composition lipidique des membranes." } }, { "@type": "Question", "name": "Quels traitements ciblent les membranes cellulaires ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments comme les statines modifient la composition lipidique." } }, { "@type": "Question", "name": "Comment les lipides peuvent-ils être manipulés ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques de nanomédecine utilisent des liposomes pour délivrer des médicaments." } }, { "@type": "Question", "name": "Quels suppléments peuvent améliorer la santé membranaire ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les acides gras oméga-3 sont bénéfiques pour la fluidité membranaire." } }, { "@type": "Question", "name": "Comment les antioxydants aident-ils les membranes ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Ils protègent les membranes contre l'oxydation et le stress oxydatif." } }, { "@type": "Question", "name": "Quels traitements sont utilisés pour les maladies membranaires ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies géniques peuvent corriger des défauts dans les membranes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des membranes altérées ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des maladies cardiovasculaires et métaboliques peuvent en résulter." } }, { "@type": "Question", "name": "Comment les membranes affectent-elles le cancer ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des modifications membranaires peuvent favoriser la progression tumorale." } }, { "@type": "Question", "name": "Quels troubles neurologiques sont liés aux membranes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des maladies comme la sclérose en plaques sont associées à des anomalies membranaires." } }, { "@type": "Question", "name": "Comment les infections impactent-elles les membranes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les agents pathogènes peuvent perturber l'intégrité des membranes cellulaires." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une défaillance membranaire ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une défaillance peut entraîner des troubles métaboliques graves et des inflammations." } }, { "@type": "Question", "name": "Quels facteurs génétiques influencent la santé membranaire ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des mutations dans les gènes liés aux lipides peuvent affecter la membrane." } }, { "@type": "Question", "name": "Comment l'alimentation impacte-t-elle les membranes ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en graisses saturées peut altérer la fluidité membranaire." } }, { "@type": "Question", "name": "Quels comportements augmentent le risque de maladies membranaires ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme et la sédentarité sont des comportements à risque." } }, { "@type": "Question", "name": "Comment l'âge affecte-t-il la santé des membranes ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Le vieillissement peut entraîner une rigidité accrue des membranes cellulaires." } }, { "@type": "Question", "name": "Quels facteurs environnementaux sont des risques pour les membranes ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "L'exposition à des toxines et à des polluants peut endommager les membranes." } } ] } ] }

Sources (377 au total)

COVID-19 compromises iron homeostasis: Transferrin as a target of investigation.

Since the beginning of the COVID-19 pandemic, numerous metabolic alterations have been observed in individuals with this disease. It is known that SARS-CoV-2 can mimic the action of hepcidin, altering... To profile iron, ferritin and hepcidin levels and transferrin receptor gene expression in patients diagnosed with COVID-19 between June 2020 and September 2020.... Cross-sectional study that evaluated iron metabolism markers in 427 participants, 218 with COVID-19 and 209 without the disease.... The primary exposure was positive diagnose to COVID-19 in general population of Santo André and São Bernardo cities. The positive and negative diagnose were determinate through RT-qPCR.... Devido a evidências de alterações do ciclo do ferro em pacientes diagnosticados com COVID-19 e devido a corregulação entre hepcidina e receptor de transferrina, uma análise da expressão gênica deste ú... Serum iron presented lower values in individuals diagnosed with COVID-19, whereas serum ferritin presented much higher values in infected patients. Elderly subjects had lower serum iron levels and hig... COVID-19 causes changes in several iron cycle pathways, with iron and ferritin levels being markers that reflect the state and evolution of infection, as well as the prognosis of the disease. The incr...

Preparation of transferrin-targeted temozolomide nano-micelles and their anti-glioma effect.

This study aims to develop brain-targeted temozolomide (TMZ) nanograins using the biodegradable polymer material PEG-PLA as a carrier. The model drug TMZ was encapsulated within the polymer using targ... Transmission electron microscopy (TEM) and Malvern size analyzer were employed to observe the morphological and particle size features of the TMZ nanospheres at various time points to assess stability... The targeted TMZ nano-micelles were successfully synthesized. After loading and targeted modifications, the particle size increased from 50.7 to 190 nm, indicating successful encapsulation of TMZ. The... TMZ-loaded nano-micelles demonstrated a gradual release profile and significantly enhanced inhibitory effects on human glioma U251 cells compared to TMZ alone. The findings suggest that TMZ-loaded PEG...